Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy IMARA stock

Own IMARA stock in just a few minutes.

IMARA Inc is a biotechnology business based in the US. IMARA shares (IMRA) are listed on the NASDAQ and all prices are listed in US Dollars. IMARA employs 27 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in IMARA

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IMRA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

IMARA share price

Use our graph to track the performance of IMRA stocks over time.

IMARA shares at a glance

Information last updated 2021-04-29.
52-week range$6.61 - $62.71
50-day moving average $8.46
200-day moving average $15.49
Wall St. target price$37.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.42

Buy IMARA shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy IMARA stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IMARA financials

Gross profit TTM $0
Return on assets TTM -41.99%
Return on equity TTM -72.98%
Profit margin 0%
Book value N/A
Market capitalisation $127.4 million

TTM: trailing 12 months

Shorting IMARA shares

There are currently 727,520 IMARA shares held short by investors – that's known as IMARA's "short interest". This figure is 18.9% up from 611,898 last month.

There are a few different ways that this level of interest in shorting IMARA shares can be evaluated.

IMARA's "short interest ratio" (SIR)

IMARA's "short interest ratio" (SIR) is the quantity of IMARA shares currently shorted divided by the average quantity of IMARA shares traded daily (recently around 115662.95707472). IMARA's SIR currently stands at 6.29. In other words for every 100,000 IMARA shares traded daily on the market, roughly 6290 shares are currently held short.

However IMARA's short interest can also be evaluated against the total number of IMARA shares, or, against the total number of tradable IMARA shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IMARA's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 IMARA shares in existence, roughly 40 shares are currently held short) or 0.0924% of the tradable shares (for every 100,000 tradable IMARA shares, roughly 92 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against IMARA.

Find out more about how you can short IMARA stock.

IMARA share dividends

We're not expecting IMARA to pay a dividend over the next 12 months.

IMARA overview

IMARA Inc. , a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. It develops IMR-687, an oral, once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site